sofosbuvir has been researched along with Diabetes Mellitus, Adult-Onset in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 4 (66.67) | 2.80 |
Authors | Studies |
---|---|
Buti, M; Castellanos Fernández, MI; Chan, WK; Duseja, A; El-Kassas, M; Esmat, G; Gordon, SC; Hamid, S; Henry, L; Isakov, V; Lam, B; Méndez-Sánchez, N; Nader, F; Ong, JP; Papatheodoridis, G; Racila, A; Romero-Gómez, M; Stepanova, M; Yilmaz, Y; Younossi, I; Younossi, ZM; Yu, ML; Ziayee, M | 1 |
Abdel Moneim, A; Mabrouk, D; Mahmoud, B; Suleiman, HA; Zaky, MY | 1 |
Abdel Alem, S; Abdellatif, Z; Abdo, M; Moustafa, A; Rabiee, A | 1 |
Abdel Alem, S; Abdellatif, Z; Adel, E; Elsharkawy, A; Esmat, G; Fouad, R; Hussein, MS; Musa, S; Nagy, A; Yosry, A | 1 |
Bahra, M; Blaeker, H; Dürr, M; Eurich, D; Eurich, F; Globke, B; Maurer, MM; Pratschke, J; Teegen, EM; Vollbort, A | 1 |
Allam, AS; Hussein, HA; Moaty, ASA | 1 |
1 trial(s) available for sofosbuvir and Diabetes Mellitus, Adult-Onset
Article | Year |
---|---|
Viral clearance ameliorates hematological and inflammatory markers among diabetic patients infected with hepatitis C genotype 4.
Topics: Adult; Antiviral Agents; Biomarkers; Carbamates; Diabetes Mellitus, Type 2; Female; Genotype; Glycated Hemoglobin; Hepacivirus; Hepatitis C; Humans; Imidazoles; Inflammation; Insulin Resistance; Interleukin-1beta; Male; Middle Aged; Pyrrolidines; Sofosbuvir; Sustained Virologic Response; Treatment Outcome; Valine | 2020 |
5 other study(ies) available for sofosbuvir and Diabetes Mellitus, Adult-Onset
Article | Year |
---|---|
Severe impairment of patient-reported outcomes in patients with chronic hepatitis C virus infection seen in real-world practices across the world: Data from the global liver registry.
Topics: Antiviral Agents; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Fatigue; Female; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Patient Reported Outcome Measures; Quality of Life; Registries; Sofosbuvir | 2022 |
Impact of sustained virological response on metabolic disorders in diabetic chronic hepatitis C virus patients after treatment with generic sofosbuvir and daclatasvir.
Topics: Antiviral Agents; Carbamates; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Imidazoles; Pyrrolidines; Retrospective Studies; Ribavirin; Sofosbuvir; Treatment Outcome; Valine | 2021 |
Improvement of glycemic state among responders to Sofosbuvir-based treatment regimens: Single center experience.
Topics: Aged; Antiviral Agents; Blood Glucose; Diabetes Mellitus, Type 2; Egypt; Female; Glycated Hemoglobin; Glycemic Index; Hepacivirus; Hepatitis C, Chronic; Humans; Insulin Resistance; Liver Cirrhosis; Male; Middle Aged; Retrospective Studies; Ribavirin; Sofosbuvir | 2017 |
Evaluation of histological dynamics, kidney function and diabetes in liver transplant patients after antiviral treatment with direct-acting antivirals: Therapy of HCV-recurrence.
Topics: Aged; Aged, 80 and over; Allografts; Antiviral Agents; Biopsy; Diabetes Mellitus, Type 2; Drug Therapy, Combination; End Stage Liver Disease; Female; Fibrosis; Glomerular Filtration Rate; Hepacivirus; Hepatitis C, Chronic; Humans; Kidney; Liver; Liver Transplantation; Male; Middle Aged; Recurrence; Sofosbuvir; Sustained Virologic Response | 2019 |
Evaluation of Glycated Haemoglobin (HbA1c) Level in Type 2 Diabetic Chronic HCV Non-cirrhotic Treatment-Naïve Egyptian Patients Eradicated with Sofosbuvir Plus Daclatasvir.
Topics: Antiviral Agents; Blood Glucose; Carbamates; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Egypt; Female; Glycated Hemoglobin; Hepatitis C, Chronic; Humans; Imidazoles; Male; Middle Aged; Prospective Studies; Pyrrolidines; Risk Factors; Sofosbuvir; Treatment Outcome; Valine | 2020 |